Novel vaccination strategies /

Saved in:
Bibliographic Details
Imprint:Weinheim : Wiley-VCH, c2004.
Description:xlii, 628 p. : ill. (some col.) ; 25 cm.
Language:English
Subject:
Format: Print Book
URL for this record:http://pi.lib.uchicago.edu/1001/cat/bib/5149649
Hidden Bibliographic Details
Other authors / contributors:Kaufmann, S. H. E. (Stefan H. E.)
ISBN:3527305238 (hd. bd.)
Notes:Includes bibliographical references and index.

MARC

LEADER 00000cam a2200000 a 4500
001 5149649
003 ICU
005 20050803152000.0
008 040401s2004 gw a b 001 0 eng d
020 |a 3527305238 (hd. bd.) 
040 |a *OHX*  |c *OHX*  |d OCLCQ  |d IaAS  |d TxU  |d CU  |d CStRLIN  |d OrLoB-B  |d UtOrBLW 
245 0 0 |a Novel vaccination strategies /  |c edited by Stefan H.E. Kaufmann. 
260 |a Weinheim :  |b Wiley-VCH,  |c c2004. 
300 |a xlii, 628 p. :  |b ill. (some col.) ;  |c 25 cm. 
336 |a text  |b txt  |2 rdacontent  |0 http://id.loc.gov/vocabulary/contentTypes/txt 
337 |a unmediated  |b n  |2 rdamedia  |0 http://id.loc.gov/vocabulary/mediaTypes/n 
338 |a volume  |b nc  |2 rdacarrier  |0 http://id.loc.gov/vocabulary/carriers/nc 
504 |a Includes bibliographical references and index. 
505 0 0 |g 1.  |t Challenges for the Vaccine Developer, including Correlates of Protection /  |r Gustav J. V. Nossal --  |g 2.  |t Shaping Adaptive Immunity against Pathogens: The Contribution of Innate Immune Responses /  |r Stefan Ehlers and Silvia Bulfone-Paus --  |g 3.  |t Adjuvant-induced Th2- and Th1-dominated Immune Responses in Vaccination /  |r James M. Brewer and Kevin G. J. Pollock --  |g 4.  |t Memory /  |r Alexander Ploss and Eric G. Pamer --  |g 5.  |t T Cell-based Vaccines /  |r Katharina M. Huster, Kristen M. Kerksiek and Dirk H. Busch --  |g 6.  |t Microbial Adjuvants /  |r Klaus Heeg, Stefan Zimmermann and Alexander Dalpke --  |g 7.  |t Host-derived Adjuvants /  |r Norbert Hilf, Markus Radsak and Hansjorg Schild --  |g 8.  |t Microparticles as vaccine adjuvants and delivery systems /  |r Derek T. O'Hagan and Manmohan Singh --  |g 9.  |t Liposomes and ISCOMs /  |r Gideon Kersten, Debbie Drane, Martin Pearse, Wim Jiskoot and Alan Coulter --  |g 10.  |t Virosomal Technology and Mucosal Adjuvants /  |r Jean-Francois Viret, Christian Moser, Faiza Rharbaoui, Ian C. Metcalfe and Carlos A. Guzman --  |g 11.  |t Classical Bacterial Vaccines /  |r Thomas Ebensen, Claudia Link and Carlos A. Guzman --  |g 12.  |t Subunit Vaccines and Toxoids /  |r Maria Lattanzi, Giuseppe Del Giudice and Rino Rappuoli --  |g 13.  |t Engineering Virus Vectors for Subunit Vaccines /  |r Joseph Patrick Nkolola and Tomas Hanke --  |g 14.  |t Update on antiviral DNA vaccine research (2000-2003) /  |r Daniel Franke, Jovan Pavlovic, Tillmann S. Utesch, Max von Kleist, Jan Schultz, Guenter Dollenmaier and Karin Moelling --  |g 15.  |t Live Recombinant Bacterial Vaccines /  |r Simon Clare and Gordon Dougan --  |g 16.  |t Mucosal Vaccination /  |r Wieslawa Olszewska and Peter J. M. Openshaw --  |g 17.  |t Passive Vaccination and Antidotes: A Novel Strategy for Generation of Wide-spectrum Protective Antibodies /  |r Antonio Cassone and Luciano Polonelli --  |g 18.  |t Plant-based Oral Vaccines /  |r Kan Wang, Rachel Chikwamba and Joan Cunnick --  |g 19.  |t Virus-like Particles: Combining Innate and Adaptive Immunity for Effective Vaccination /  |r Martin F. Bachmann and Gary T. Jennings --  |g 20.  |t Helicobacter pylori /  |r Paolo Ruggiero, Rino Rappuoli and Giuseppe Del Giudice --  |g 21.  |t Novel Vaccination Strategies against Tuberculosis /  |r Stefan H. E. Kaufmann --  |g 22.  |t Rationale for Malaria Vaccine Development /  |r Allan Saul, Victor Nussenzweig and Ruth S. Nussenzweig --  |g 23.  |t Vaccine for Specific Targets: HIV /  |r R. Kay, Edmund G.-T. Wee and Andrew J. McMichael --  |g 24.  |t Vaccines against Bioterror Agents /  |r Karen L. Elkins, Drusilla L. Burns, Michael P. Schmitt and Jerry P. Weir --  |g 25.  |t Imperfect Vaccines and the Evolution of Pathogen Virulence /  |r Paul W. Ewald --  |g 26.  |t Cost-Effectiveness of Vaccinations /  |r Thomas D. Szucs --  |g 27.  |t Immunological Safety of Vaccines: Facts, Hypotheses and Allegations /  |r Michel Goldman and Paul-Henri Lambert. 
650 0 |a Vaccines.  |0 http://id.loc.gov/authorities/subjects/sh85141718 
650 0 |a Vaccines  |x Synthesis. 
650 7 |a Vaccines.  |2 fast  |0 http://id.worldcat.org/fast/fst01163573 
650 7 |a Vaccines  |x Synthesis.  |2 fast  |0 http://id.worldcat.org/fast/fst01163588 
700 1 |a Kaufmann, S. H. E.  |q (Stefan H. E.)  |0 http://id.loc.gov/authorities/names/no90008889  |1 http://viaf.org/viaf/85701743 
901 |a ToCBNA 
903 |a HeVa 
903 |a Hathi 
035 |a (OCoLC)52746661 
929 |a cat 
999 f f |i 6edc9554-4dbb-55ce-ae21-7aafe9c75a00  |s 6c8b9449-510f-5a78-a61b-9d2d27a97306 
928 |t Library of Congress classification  |a QR189 .N68 2004  |l JCL  |c JCL-Sci  |i 6484198 
927 |t Library of Congress classification  |a QR189 .N68 2004  |l JCL  |c JCL-Sci  |e GDON  |e CRERAR  |b 65676228  |i 7684199